CRAYON
Every story · every side  ·  est. 1995
Business

GH Research's $1.2B Depression Drug Opportunity Still Has Analysts Buying the Dip

Photo: Benzinga
▲ Sign in to vote stories up

Coverage 1 source · 1 report

Chronological.

  1. Benzinga FIRST 6d ago GH Research's $1.2B Depression Drug Opportunity Still Has Analysts Buying the Dip

Discussion 0 comments